CMCMX | NRGEX | CMCMX / NRGEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 3 years | - |
Gain YTD | -0.627 | -2.121 | 30% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.5M | 9.89B | 0% |
Annual Yield % from dividends | 0.00 | 0.89 | - |
Returns for 1 year | 12.64 | 5.00 | 253% |
Returns for 3 years | -5.03 | 0.93 | -538% |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GDLFX | 19.28 | -0.01 | -0.05% |
Gotham Defensive Long 500 Institutional | |||
PHSZX | 44.94 | -0.24 | -0.53% |
PGIM Jennison Health Sciences Z | |||
TGIHX | 15.24 | -0.31 | -1.99% |
Nuveen Core Equity I | |||
BPSIX | 26.20 | -0.57 | -2.13% |
Boston Partners Small Cap Value II I | |||
FRSLX | 25.75 | -1.16 | -4.31% |
Nuveen Mid Cap Growth Opps A |